Nicholson Garry A 4
4 · TScan Therapeutics, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Nicholson Garry A
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-12+47,500→ 47,500 totalExercise: $8.88Exp: 2034-06-11→ Voting Common Stock (47,500 underlying) - Award
Stock Option (Right to Buy)
2024-06-12+23,750→ 23,750 totalExercise: $8.88Exp: 2034-06-11→ Voting Common Stock (23,750 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time.
- [F2]The shares subject to this option shall vest and become exercisable with respect to one-third of the shares on June 12, 2025, with the balance vesting thereafter in 24 equal monthly installments, subject to the Reporting Person's continued service at each such time.